| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1111/J.1600-065X.2007.00554.X |
| P698 | PubMed publication ID | 17850490 |
| P2093 | author name string | Göran K Hansson | |
| Zhong-qun Yan | |||
| P2860 | cites work | A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection | Q59068486 |
| Toll-like Receptor 4 Polymorphisms and Atherogenesis | Q59273869 | ||
| A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease | Q22251291 | ||
| TLR4 mutations are associated with endotoxin hyporesponsiveness in humans | Q22254186 | ||
| Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene | Q22299417 | ||
| Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB | Q24290546 | ||
| RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems | Q24292468 | ||
| The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta | Q24305136 | ||
| IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction | Q24318426 | ||
| An endothelial receptor for oxidized low-density lipoprotein | Q24323462 | ||
| Nod1-mediated endothelial cell activation by Chlamydophila pneumoniae | Q24338210 | ||
| Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection | Q24633526 | ||
| Atherosclerosis | Q24644573 | ||
| Porphyromonas gingivalis fimbriae proactively modulate beta2 integrin adhesive activity and promote binding to and internalization by macrophages | Q24678639 | ||
| Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses | Q27860455 | ||
| The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses | Q27860685 | ||
| Pathogen recognition and innate immunity | Q27861084 | ||
| A human homologue of the Drosophila Toll protein signals activation of adaptive immunity | Q28131769 | ||
| Gout-associated uric acid crystals activate the NALP3 inflammasome | Q28131797 | ||
| Human CARD4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-kappaB | Q28142782 | ||
| Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis | Q28198287 | ||
| Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis | Q28205296 | ||
| NALPs: a novel protein family involved in inflammation | Q28206764 | ||
| The PYRIN domain: a novel motif found in apoptosis and inflammation proteins | Q28206887 | ||
| Identification of a human homologue of the dendritic cell-associated C-type lectin-1, dectin-1 | Q28208472 | ||
| The PYRIN-CARD protein ASC is an activating adaptor for caspase-1 | Q28215427 | ||
| Immune recognition. A new receptor for beta-glucans | Q28215606 | ||
| Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis | Q28236868 | ||
| Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma | Q42162162 | ||
| Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells | Q42489719 | ||
| Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages | Q42826455 | ||
| Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis | Q42944624 | ||
| Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. | Q43531684 | ||
| A role for oxidized phospholipids in atherosclerosis | Q43686230 | ||
| Hyaluronic acid and chondroitin sulphate A rapidly promote differentiation of immature DC with upregulation of costimulatory and antigen-presenting molecules, and enhancement of NF-kappaB and protein kinase activity | Q43883899 | ||
| Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice | Q43893171 | ||
| Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes | Q44011973 | ||
| Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice | Q44079670 | ||
| Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease | Q44207349 | ||
| Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications | Q44278742 | ||
| Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2. | Q44459170 | ||
| Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice | Q44484471 | ||
| Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. | Q44756938 | ||
| The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease | Q44773559 | ||
| Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways | Q44807760 | ||
| The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. | Q45025551 | ||
| Dectin-1 stimulation by Candida albicans yeast or zymosan triggers NFAT activation in macrophages and dendritic cells | Q45345622 | ||
| A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction | Q46155185 | ||
| Porphyromonas gingivalis bacteremia induces coronary and aortic atherosclerosis in normocholesterolemic and hypercholesterolemic pigs | Q46450288 | ||
| Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice | Q46551642 | ||
| Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice | Q47658739 | ||
| Regulation of effector T cells by antigen-presenting cells via interaction of the C-type lectin MGL with CD45. | Q51803715 | ||
| Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors. | Q51817209 | ||
| A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis. | Q52938770 | ||
| The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke | Q56944340 | ||
| Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction*1 | Q57607713 | ||
| IL-18 Accelerates Atherosclerosis Accompanied by Elevation of IFN-γ and CXCL16 Expression Independently of T Cells | Q57987937 | ||
| Protective Role of Interleukin-10 in Atherosclerosis | Q58150380 | ||
| High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal | Q28242907 | ||
| Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity | Q28504584 | ||
| The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors | Q28512624 | ||
| RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages | Q28568915 | ||
| LOX-1 inhibition in myocardial ischemia-reperfusion injury: modulation of MMP-1 and inflammation | Q28583634 | ||
| Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins | Q28588506 | ||
| Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex | Q28588629 | ||
| CD36 is a sensor of diacylglycerides | Q28591244 | ||
| Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice | Q28591350 | ||
| Inflammation, atherosclerosis, and coronary artery disease | Q29547232 | ||
| Toll-like receptor control of the adaptive immune responses | Q29547305 | ||
| Inflammation in atherosclerosis | Q29547428 | ||
| Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus | Q29615029 | ||
| Toll-like receptors and innate immunity | Q29615458 | ||
| Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan | Q29618544 | ||
| An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid | Q29620015 | ||
| Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large | Q33342232 | ||
| Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST) | Q33616752 | ||
| Chlamydia pneumoniae augments the oxidized low-density lipoprotein-induced death of mouse macrophages by a caspase-independent pathway | Q33883485 | ||
| Modulation of atherosclerosis in mice by Toll-like receptor 2 | Q34063165 | ||
| Retinoic acid-inducible gene-I is induced in endothelial cells by LPS and regulates expression of COX-2. | Q34118046 | ||
| NODs: intracellular proteins involved in inflammation and apoptosis | Q34199862 | ||
| Retinoic acid-inducible gene-I is induced by interferon-gamma and regulates the expression of interferon-gamma stimulated gene 15 in MCF-7 cells | Q34325109 | ||
| Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins | Q34387116 | ||
| The oxidative modification hypothesis of atherosclerosis: does it hold for humans? | Q34423117 | ||
| NOD-LRR proteins: role in host-microbial interactions and inflammatory disease | Q34426050 | ||
| Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. | Q34448382 | ||
| Regulation of lung injury and repair by Toll-like receptors and hyaluronan | Q34462186 | ||
| Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders | Q34472385 | ||
| Circuitry of nuclear factor kappaB signaling | Q34514908 | ||
| CARD15 mutations in Blau syndrome | Q34517310 | ||
| Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. | Q34544391 | ||
| The role of hyaluronan degradation products as innate alloimmune agonists. | Q34574846 | ||
| Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability | Q34601356 | ||
| Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. | Q34858442 | ||
| The macrophage foam cell as a target for therapeutic intervention | Q34986351 | ||
| Pattern recognition receptors: doubling up for the innate immune response | Q35036522 | ||
| Chlamydia pneumoniae--an infectious risk factor for atherosclerosis? | Q35701591 | ||
| Expression of interleukin-15 in mouse and human atherosclerotic lesions | Q35747016 | ||
| Dectin-1 is required for beta-glucan recognition and control of fungal infection | Q35837153 | ||
| Macrophage receptors and immune recognition | Q36072472 | ||
| No evidence of association between NOD2/CARD15 gene polymorphism and atherosclerotic events after renal transplantation | Q36232292 | ||
| Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. | Q36370968 | ||
| CATERPILLERs, pyrin and hereditary immunological disorders | Q36405072 | ||
| Nucleotide-binding oligomerization domain-like receptors: intracellular pattern recognition molecules for pathogen detection and host defense | Q36584966 | ||
| Nod-like proteins in immunity, inflammation and disease | Q36655897 | ||
| Myeloid C-type lectins in innate immunity | Q36655901 | ||
| Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation | Q36691082 | ||
| Cooperation of Toll-like receptor signals in innate immune defence | Q36743540 | ||
| Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E | Q36986664 | ||
| Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome | Q37865020 | ||
| Azithromycin for the secondary prevention of coronary events | Q37865023 | ||
| Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling. | Q37869249 | ||
| Non-LPS components of Chlamydia pneumoniae stimulate cytokine production through Toll-like receptor 2-dependent pathways | Q37872216 | ||
| Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway | Q37872780 | ||
| Predominant role of toll-like receptor 2 versus 4 in Chlamydia pneumoniae-induced activation of dendritic cells | Q37873504 | ||
| Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice | Q37874064 | ||
| Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression | Q37880399 | ||
| Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model | Q37881464 | ||
| Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells | Q40212509 | ||
| Adipocyte fatty acid-binding protein expression and lipid accumulation are increased during activation of murine macrophages by toll-like receptor agonists. | Q40459587 | ||
| CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions | Q40584986 | ||
| Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein | Q40609759 | ||
| Crosstalk between LXR and Toll-like Receptor Signaling Mediates Bacterial and Viral Antagonism of Cholesterol Metabolism | Q40622775 | ||
| Receptors involved in the oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine-mediated synthesis of interleukin-8. A role for Toll-like receptor 4 and a glycosylphosphatidylinositol-anchored protein | Q40643736 | ||
| Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling | Q40662613 | ||
| Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells | Q40691206 | ||
| Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells | Q40799740 | ||
| The extra domain A of fibronectin activates Toll-like receptor 4. | Q40832345 | ||
| Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death | Q40993289 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 187-203 | |
| P577 | publication date | 2007-10-01 | |
| P1433 | published in | Immunological Reviews | Q15724582 |
| P1476 | title | Innate immunity, macrophage activation, and atherosclerosis | |
| P478 | volume | 219 |
| Q35727586 | 6-7-Dimethoxy-4-methylcoumarin suppresses pro-inflammatory mediator expression through inactivation of the NF-κB and MAPK pathways in LPS-induced RAW 264.7 cells. |
| Q35785437 | Adiponectin-AdipoR1/2-APPL1 signaling axis suppresses human foam cell formation: differential ability of AdipoR1 and AdipoR2 to regulate inflammatory cytokine responses |
| Q37709623 | Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases |
| Q37142814 | Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis. |
| Q38685189 | Anti-inflammatory activity of hydrosols from Tetragonia tetragonoides in LPS-induced RAW 264.7 cells |
| Q37190468 | Antigen-induced immunomodulation in the pathogenesis of atherosclerosis. |
| Q44937123 | Antioxidants and phase 2 enzymes in macrophages: regulation by Nrf2 signaling and protection against oxidative and electrophilic stress |
| Q35945270 | Association between serum homocysteine concentration with coronary artery disease in Iranian patients. |
| Q30364399 | Atherosclerosis and Nanotechnology: Diagnostic and Therapeutic Applications. |
| Q37824302 | Auto-antibodies as emergent prognostic markers and possible mediators of ischemic cardiovascular diseases |
| Q37138017 | Autoimmunity in atherosclerosis: a protective response losing control? |
| Q37015268 | Autoimmunity since the 1957 clonal selection theory: a little acorn to a large oak. |
| Q33644481 | Beta2 integrins modulate the initiation and progression of atherosclerosis in low-density lipoprotein receptor knockout mice |
| Q38883924 | Bioassay-Guided Isolation of Anti-Inflammatory Components from the Bulbs of Lilium brownii var. viridulum and Identifying the Underlying Mechanism through Acting on the NF-κB/MAPKs Pathway |
| Q37729330 | Blocking TLR2 activity diminishes and stabilizes advanced atherosclerotic lesions in apolipoprotein E-deficient mice |
| Q48627436 | Blood pressure control: salt gets under your skin |
| Q36824843 | CD14 directs adventitial macrophage precursor recruitment: role in early abdominal aortic aneurysm formation. |
| Q54377997 | CD4 + CD25 + Foxp3 + Regulatory T Cells Protect the Proinflammatory Activation of Human Umbilical Vein Endothelial Cells |
| Q27333264 | Cell elasticity determines macrophage function |
| Q39363084 | Chamomile confers protection against hydrogen peroxide-induced toxicity through activation of Nrf2-mediated defense response |
| Q34519367 | Chronic exposure to perfluorinated compounds: Impact on airway hyperresponsiveness and inflammation |
| Q42923928 | Chronic unpredictable stress accelerates atherosclerosis through promoting inflammation in apolipoprotein E knockout mice |
| Q33850220 | Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression |
| Q46513033 | Development of Thiolated-Graphene Quantum Dots for Regulation of ROS in macrophages |
| Q30430289 | Differential effects of ceramide and sphingosine 1-phosphate on ERM phosphorylation: probing sphingolipid signaling at the outer plasma membrane |
| Q90720174 | Effects of Omega-3 Fatty Acids on Immune Cells |
| Q41334543 | Effects of murine norovirus infection on a mouse model of diet-induced obesity and insulin resistance |
| Q33955912 | Emerging role of IL-17 in atherosclerosis |
| Q37035830 | Enhanced production of nitric oxide, reactive oxygen species, and pro-inflammatory cytokines in very long chain saturated fatty acid-accumulated macrophages |
| Q39435171 | Evaluation of macrophage-specific promoters using lentiviral delivery in mice |
| Q34785574 | Gene Deficiency in Activating Fcγ Receptors Influences the Macrophage Phenotypic Balance and Reduces Atherosclerosis in Mice. |
| Q34079474 | Genetic network identifies novel pathways contributing to atherosclerosis susceptibility in the innominate artery |
| Q37501546 | Glucocorticoid resistance in inflammatory diseases. |
| Q38220759 | HDL in innate and adaptive immunity. |
| Q36103851 | Heme oxygenase-1, oxidation, inflammation, and atherosclerosis |
| Q37225778 | Highly absorptive curcumin reduces serum atherosclerotic low-density lipoprotein levels in patients with mild COPD |
| Q33967764 | Homocysteine and markers of inflammation in acute coronary syndrome |
| Q24631660 | Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*) |
| Q37742774 | Immunomodulatory effects of ethanol extract of germinated ice plant (Mesembryanthemum crystallinum) |
| Q42429702 | Increased expression of visfatin in monocytes and macrophages in male acute myocardial infarction patients |
| Q33597485 | Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation |
| Q33762674 | Inflammasomes are differentially expressed in cardiovascular and other tissues |
| Q28275259 | Inflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applications |
| Q54057211 | Inhibition of PDGF-induced migration and TNF-α-induced ICAM-1 expression by maltotetraose from bamboo stem extract (BSE) in mouse vascular smooth muscle cells. |
| Q33953090 | Inhibitor of growth-4 promotes IkappaB promoter activation to suppress NF-kappaB signaling and innate immunity |
| Q34980214 | Innate immunity and monocyte-macrophage activation in atherosclerosis. |
| Q41208076 | Innate immunity and remodelling |
| Q42025217 | Innate immunity and resistance to tolerogenesis in allotransplantation |
| Q41834087 | Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity |
| Q36869664 | Interrelationship Between Periapical Lesion and Systemic Metabolic Disorders |
| Q52921508 | Isolation and Differentiation of Human Macrophages. |
| Q36725904 | Lipid peroxidation and decomposition--conflicting roles in plaque vulnerability and stability |
| Q27329447 | Loss of Reelin protects against atherosclerosis by reducing leukocyte-endothelial cell adhesion and lesion macrophage accumulation |
| Q36584242 | Macrophage autophagy in atherosclerosis |
| Q26825052 | Macrophages in vascular inflammation--From atherosclerosis to vasculitis |
| Q36344968 | Marked acceleration of atherosclerosis after Lactobacillus casei-induced coronary arteritis in a mouse model of Kawasaki disease |
| Q37308942 | Mechanisms and consequences of macrophage apoptosis in atherosclerosis |
| Q35162258 | Murine norovirus increases atherosclerotic lesion size and macrophages in Ldlr(-/-) mice |
| Q24627504 | Myeloid-related protein-8/14 is critical for the biological response to vascular injury |
| Q36302873 | NADPH oxidases: an overview from structure to innate immunity-associated pathologies |
| Q26822962 | Oxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosis |
| Q43120971 | Paraoxonase 2 Induces a Phenotypic Switch in Macrophage Polarization Favoring an M2 Anti-Inflammatory State |
| Q38080410 | Pathogenic arterial remodeling: the good and bad of microRNAs |
| Q55240484 | Polyclonal human antibodies against glycans bearing red meat-derived non-human sialic acid N-glycolylneuraminic acid are stable, reproducible, complex and vary between individuals: Total antibody levels are associated with colorectal cancer risk. |
| Q34975175 | Proteomics of acute coronary syndromes |
| Q42577777 | Regulatory T cells and Atherosclerosis |
| Q37309036 | Resistin-like molecule alpha enhances myeloid cell activation and promotes colitis |
| Q39677021 | Rhizoma Coptidis inhibits LPS-induced MCP-1/CCL2 production in murine macrophages via an AP-1 and NFkappaB-dependent pathway |
| Q33352793 | Role of placenta growth factor in cancer and inflammation |
| Q37454661 | Roles and regulation of secretory and lysosomal acid sphingomyelinase |
| Q40094430 | Saliva/serum ghrelin, obestatin and homocysteine levels in patients with ischaemic heart disease |
| Q37076061 | Systematic Evaluation of the Cellular Innate Immune Response During the Process of Human Atherosclerosis |
| Q37143018 | T-cell costimulation and coinhibition in atherosclerosis. |
| Q58045474 | The ageing immune system and its clinical implications |
| Q54291298 | The effects of ox-LDL in human atherosclerosis may be mediated in part via the toll-like receptor 4 pathway. |
| Q34068668 | The probable role of cytomegalovirus in acute myocardial infarction. |
| Q28264081 | Three-dimensional migration of macrophages requires Hck for podosome organization and extracellular matrix proteolysis |
| Q35021053 | Thyroid and bone: macrophage-derived TSH-β splice variant increases murine osteoblastogenesis. |
| Q38053492 | Toll-like receptor signaling pathways in cardiovascular diseases: challenges and opportunities |
| Q37810915 | Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets |
| Q91794636 | Tumor Necrosis Factor-α in Heart Failure: an Updated Review |
| Q37488133 | Unlocking bat immunology: establishment of Pteropus alecto bone marrow-derived dendritic cells and macrophages. |
| Q37077297 | VASCULAR INFLAMMATION AND ATHEROGENESIS ARE ACTIVATED VIA RECEPTORS FOR PAMPs AND SUPPRESSED BY REGULATORY T CELLS. |
| Q86509911 | VB-201, an oxidized phospholipid small molecule, inhibits CD14- and Toll-like receptor-2-dependent innate cell activation and constrains atherosclerosis |
| Q37495603 | Vaccination against atherosclerosis? Induction of atheroprotective immunity |
| Q39519472 | WNT/β-catenin pathway is modulated in asthma patients and LPS-stimulated RAW264.7 macrophage cell line |
Search more.